Twin Crossover Relative Potency Analgesic Assays in Man. II. Morphine Vs. 8‐Methoxycyclazocine
- 9 August 1977
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 17 (8-9) , 480-489
- https://doi.org/10.1002/j.1552-4604.1977.tb05640.x
Abstract
Using the twin crossover, balanced incomplete block design, a double-blind determination of the relative analgesic potency of graded i.m. doses of Win 20,836 (8-methoxycyclazocine) and morphine was carried out in patients with postoperative pain. The occurrence of psychotomimetic side-effects prevented the administration of Win 20,836 equieffective with the morphine standard and this necessitated substantial extrapolation of the dose-response curve of the test drug to arrive at a relative potency estimate. The relative potency estimate, which indicated that Win 20,836 is 3-6 times as potent as morphine, was dependable enough to predict that Win 20,836 doses equieffective to the usual morphine doses would produce an unacceptable level of psychotomimetic side-effects.This publication has 3 references indexed in Scilit:
- Twin Crossover Relative Potency Analgesic Assays in Man. I. Morphine Vs. MorphineThe Journal of Clinical Pharmacology, 1977
- A clinical comparison of the effects of oral and intramuscular administration of analgesics: Pentazocine and phenazocineClinical Pharmacology & Therapeutics, 1968
- On Cross‐over Tests with a Graded Response: Statistical Analyses and the Concept of the “Log‐dose Difference Response‐Difference Line”.Acta Pharmacologica et Toxicologica, 1961